Different expression patterns of MMP-2 and MMP-9 in breast cancer

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 875-879

  Rha, Sun Young ^a,b   Yang, Woo Ick ^a   Kim, Joo Hang ^a,b   Roh, Jae Kyung ^a,b   Min, Jin Sik ^a,b   Lee, Kyong Sik ^a   Kim, Byung Soo ^a,b   Chung, Hyun Cheol ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Breast cancer; MMP 2; MMP 9

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0038192185     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.875     Document Type: Article

References (30)

1. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303, 1990.
2. Tryggvason K, Hoyhtya M and Pyke C: Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24: 209-218, 1993.
3. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
4. Azzam HS, Arand GA, Lippman ME and Thompson EW: MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J Natl Cancer Inst 85: 1758-1764, 1993.
5. Levy AT, Cioce V, Sobel ME, et al: Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51: 439-444, 1991.
6. Stearns ME and Wang M: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53: 878-883, 1993.
7. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG: Immunohistochemical distribution and type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136: 585-592, 1990.
8. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A and Balkwill F: Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53: 5365-5369, 1993.
9. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC and Carmichael J: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 8: 574-578, 1993.
10. Nomura H, Fujimoto N, Seiki M, Mai M and Kadad Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase-2 (Gelatinase A) in human gastric carcinomas. Int J Cancer 69: 9-16, 1996.
11. Lee KS, Rha SY, Kim SJ, Kim JH, Roh JK, Kim BS and Chung HC: Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin Exp Metastasis 14: 512-519, 1996.
12. Rha SY, Kim JH, Roh JK, Lee KS, Min JS, Kim BS and Chung HC: Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res Treat 43: 175-181, 1997.
13. Noh SH, Lee CI, Chung HC, Park JO, Cho JY, Rha SY, You NC, Kim JH, Roh JK, Min JS, Kim BS and Lee KB: Expression and clinical relevance of collagen-IV & Type-IV collagenase in gastric cancer. Korea J Gastroenterology 28: 1-10, 1996.
14. Chung HC, Cho JY, Rha SY, Park JO, Ahn JB, Lee CI, Yoo NC, Kim JH, Roh JK, Noh SH, Min JS, Kim BS, Lim HY and Choi JH: Expression of matrix-metalloproteinases (MMP-2, MMP-9) in gastric cancer as new targets for biotherapy. J Korean Cancer Associaton 27: 897-906, 1995.
15. Stetler-Stevenson WG, Krutzsch HC, Wachner MP, Marguiles IMK and Liotta LA: The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264: 1353-1356, 1989.
16. Brown PD, Bloxidge RE, Anderson E and Howell A: Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11: 183-189, 1993.
17. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994.
18. Nomura H, Sato H, Seiki M, Masayoshi M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
19. Yu M, Sato H, Seiki M and Thompson EW: Complex regulation of MT-MMP expression and MMP-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55: 3272-3277, 1995.
20. Fridman R, Toth M, Pena D and Mobashery S: Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55: 2548-2555, 1995.
21. De Clark YA, Yean TD, Lu HS, Ting J and Langley KE: Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem 266: 3893-3899, 1991.
22. Polette M, Clavel C, Cockett M, Girod de Bentzmann S, Murphy G and Birembaut P: Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 13: 31-37, 1993.
23. Testa JE and Quigley JP: Reversal of misfortune: TIMP-2 inhibits turner cell invasion. J Natl Cancer Inst 83: 740-742, 1991.
24. Albini A, MeIchiori A, Santi L, Liotta LA, Brown PD and Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83: 775-779, 1991.
25. Liotta LA and Stetler-Stevenson G: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
26. Beahrs OH and Meyers MH: In: Manual for Staging of Cancer. Beahrs OH, Hensen DE, Hutter RVP and Kennedy BJ (Eds) Lippincott, Philadelphia pp149-154, 1992.
27. Doussal VL, Tubiana-Hulin M, Friedman S, Hacerne K, Spyratos F and Brunet M: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): an improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64: 1914-1922, 1989.
28. Shi YE, Torri J, Tieh L, Wellstein A, Lippman ME and Dickson RB: Identification and characterization of a novel matrix-degrading protease from hormone-dependent human cancer cells. Cancer Res 53: 1409-1415, 1993.
29. Kleiner DE and Stetler-Stevenson WG: Quantitative zymography: detection of picogram quantities of gelatinase. Anal Biochem 218: 325-329, 1994.
30. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD and Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993.